Appointment
Crescendo Biologics: Aid for late-stage development
Previously, Bland-Ward held senior positions at Cambridge Antibody Technology and PanGenetics and was CSO at Navion, as well as a co-founder of Nascient. He holds a BPharm degree in pharmacy and a PhD in pharmacology, both from King’s College London, and started his career working on pain and migraine research at the Glaxo Institute of Applied Pharmacology and then at GlaxoWellcome.